Parkside Financial Bank & Trust’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,033
Closed -$56K 1959
2021
Q3
$56K Buy
3,033
+53
+2% +$1.07K 0.02% 476
2021
Q2
$64K Buy
2,980
+59
+2% +$1.2K 0.02% 444
2021
Q1
$56K Buy
+2,921
New +$51.5K 0.02% 454

Other funds holding OCDX

Parkside Financial Bank & Trust's OCDX Position: Q4 2021 in Review

Parkside Financial Bank & Trust sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q4 2021, closing a stake of 3,033 shares — an estimated $56K sold.

Parkside Financial Bank & Trust first reported a position in OCDX in Q1 2021 and held it in 3 quarters. The position peaked at $64K in Q2 2021. 162 funds tracked by Wall St. Rank hold OCDX as of Q4 2021.

  • Parkside Financial Bank & Trust reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 3,033 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q4 2021, an estimated $56K.
  • Parkside Financial Bank & Trust first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 3 quarters.
  • Parkside Financial Bank & Trust's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $64K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q4 2021.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2021, filed 14 Feb 2022.